Radha Shah Parmar

USPTO Granted Patents = 9 (Patent Applications = 14)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 14)

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 44(Granted Patents)

Company Filing History:

6 out of 230

Glaxosmithkline Intellectual Property Development Limited

Years Active: 2016-2022

Loading Chart...

9 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11419945 - Antigen binding proteins (2022-08-23),

2. 11130811 - ICOS binding proteins (2021-09-28),

3. 11078287 - Binding agonist for treatment of neurological and other disorders (2021-08-03),

4. 10351627 - ICOS binding proteins (2019-07-16),

5. 9914781 - Binding agonist for treatment of neurological and other disorders (2018-03-13),

6. 9771424 - ICOS binding proteins (2017-09-26),

7. 9738718 - ICOS binding proteins (2017-08-22),

8. 9394374 - Antigen-binding proteins (2016-07-19),

9. 9273141 - B cell maturation antigen (BCMA) binding proteins (2016-03-01),

Title: Radha Shah Parmar: Innovator in Antigen Binding Proteins

Introduction

Radha Shah Parmar is a distinguished inventor based in Stevenage, GB, known for her significant contributions to the field of biotechnology. With a total of nine patents to her name, she has made remarkable advancements in the development of antigen binding proteins.

Latest Patents

Among her latest patents, one focuses on antigen binding proteins that specifically bind to B Cell Maturation Antigen (BCMA). This invention aims to inhibit the binding of BAFF and APRIL to the BCMA receptor, providing potential therapeutic applications. Another notable patent involves ICOS binding proteins that act as agonists to human ICOS. These proteins do not induce complement, ADCC, or CDC when in contact with T cells in vivo. They are designed to treat cancer, infectious diseases, and sepsis, while also stimulating T cell proliferation and cytokine production.

Career Highlights

Radha has worked with prominent companies such as GlaxoSmithKline Intellectual Property Development Limited and Glaxo Group Limited. Her work in these organizations has allowed her to develop innovative solutions in the field of immunology and therapeutic treatments.

Collaborations

Throughout her career, Radha has collaborated with notable colleagues, including Patrick A Mayes and Alan Peter Lewis. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Radha Shah Parmar is a pioneering inventor whose work in antigen binding proteins has the potential to revolutionize treatments for various diseases. Her contributions to biotechnology continue to inspire and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.